N@N

Luca Issi Reiterated (ARWR) at Buy and Held Target at $50 on, Jan 16th, 2024

Luca Issi of RBC Capital, Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy and Held Target at $50 on, Jan 16th, 2024.

Luca has made no other calls on ARWR in the last 4 months.

There are 3 other peers that have a rating on ARWR. Out of the 3 peers that are also analyzing ARWR, 2 agree with Luca's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $37 on, Thursday, November 30th, 2023
• Shawn Egan of "Citigroup" Initiated at Hold and Held Target at $33 on, Tuesday, September 19th, 2023

This is the rating of the analyst that currently disagrees with Luca

---

• Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $37 on, Tuesday, January 2nd, 2024

Contributing Sources

---